Home / News / JensonR+ is a Joint Venture Partner of the regulanet®

JensonR+ is a Joint Venture Partner of the regulanet®

Medilink East Midlands Patron organisation JensonR+ is a Joint Venture Partner in international regulatory network regulanet®

regulanet® is a network of independent regulatory affairs consultancies with representation in over 90 countries throughout the world. Founded in 2001 by Medilink EM Member Dr Regenold GmbH, regulanet® offers services to a wide variety of national and international healthcare and pharmaceutical clients. The members of the network provide advice and assistance on national and international projects and marketing authorisation procedures, including the decentralised, mutual recognition and centralised procedures within Europe.

Over the years, the services offered by our members and partners have expanded to include all facets of development, regulation, and market access. The full regulanet® database contains contact details, a service summary of each member, and a link to their website. Jenson R+ provide advice and signposting and works with its partners within Europe.

Services offered by regulanet® include:

• Strategic advice
• Pharmaceutical development
• Preclinical development
• Clinical development
• Medical writing
• Project management
• Regulatory strategy and implementation
• QM systems, licenses and compliance
• Pharmacovigilance
• Data science & analytics
• Market access
• Portfolio analysis & life cycle management
• Due diligence

JensonR+ is a technical consultancy which aims to promote better health through simplifying the journey from innovation to the marketplace.

They achieve this through offering wide-ranging services to cover the full product life-cycle, from concept through to launch and beyond.

Their specialist team is experienced in regulatory affairs, product development, quality assurance, drug safety, medical information, copy approval, project management, training and market access. They can provide support at all levels, from strategy through to administration, which allows them to tailor their services as their clients move from innovation and development to the market place.

Medilink EM Patronage is offered to organisations because of their prominence within the East Midlands and their recognition of the importance of life sciences in the region. Patrons also appreciate the positive contribution that Medilink EM makes to the sector through its business support activities. JensonR+ has been a Patron of Medilink East Midlands since November 2019.

For more information on the regulanet®, click here

For more information on Medilink EM Patronage, click here

Check Also

PHARMASEAL are offering Engility CTMS at no cost to support Phase II clinical trials in return for BETA testing

Engility® trial management platform developed by PHARMASEAL provides a solution to overcome many traditional challenges …